Overview

This opportunity offers investors access to a pre-IPO public equity investment in a pharmaceutical manufacturing platform being relaunched in Southeast Europe through a listed European holding structure. The project involves integrating an established pharmaceutical company into a publicly traded vehicle, allowing investors to participate in the early growth phase before a potential public market expansion and valuation uplift.

What the Business Does

The company focuses on the manufacturing and commercialization of pharmaceutical products, generics, and food supplements, supported by a refurbished production facility with significant capacity. The site is being modernized and prepared to obtain Serbian and European GMP certifications, enabling the company to produce medicines both for its own product portfolio and for third-party pharmaceutical partners.

Growth Strategy

The growth strategy is based on a multi-revenue model, including generic drug licensing, own-branded prescription medicines, food supplements, contract manufacturing, and participation in pharmaceutical tenders. The project aims to scale operations after certification and gradually expand into regional and international markets while benefiting from the growing pharmaceutical demand in Southeast Europe.

Investment Highlights

• Pre-IPO investment with planned public market positioning
• Exposure to the defensive healthcare and generics sector
• Refurbished pharmaceutical production infrastructure with large capacity
• Multiple revenue streams and expansion into regional export markets
• Clear operational milestones tied to certification, production ramp-up, and commercialization.

Asset Class: Public Equity

Deal Type: Pre-IPO / capital increase in kind

Sector: Healthcare / Pharmaceuticals / Generics

Jurisdiction: Germany / Serbia / Cyprus structure

Stage: Growth / turnaround / pre-commercial ramp-up

Target Raise: EUR 12m

Target IPO Size: EUR 60m

The post Strategic Revitalization of an asset-backed, Pharmaceutical Manufacturing Platform with pre-IPO upside in Serbia appeared first on Najafi Capital Deal Making Platform.